Exploring Definitive Healthcare Corp. (DH) Investor Profile: Who’s Buying and Why?

Exploring Definitive Healthcare Corp. (DH) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Healthcare Information Services | NASDAQ

Definitive Healthcare Corp. (DH) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Definitive Healthcare Corp. (DH) and Why?

Investor Profile Analysis for Definitive Healthcare Corp. (DH)

Key Investor Types

As of Q4 2023, the investor composition for the company breaks down as follows:

Investor Category Percentage Ownership
Institutional Investors 84.7%
Mutual Funds 52.3%
Individual/Retail Investors 15.3%

Top Institutional Investors

  • Vanguard Group Inc: 12.4% ownership
  • BlackRock Inc: 9.7% ownership
  • Fidelity Management & Research: 7.2% ownership

Investment Motivations

Key investment attractors include:

  • Revenue Growth Rate: 14.2% year-over-year
  • Market Position in Healthcare Data Analytics
  • Consistent Quarterly Performance

Investment Strategy Breakdown

Strategy Type Percentage of Investors
Long-Term Hold 67.5%
Short-Term Trading 18.3%
Value Investing 14.2%

Financial Performance Metrics

  • Stock Price (as of January 2024): $23.45
  • Market Capitalization: $1.8 billion
  • Price-to-Earnings Ratio: 42.6



Institutional Ownership and Major Shareholders of Definitive Healthcare Corp. (DH)

Investor Profile Analysis for Definitive Healthcare Corp. (DH)

Key Investor Types

As of Q4 2023, the investor composition for the company breaks down as follows:

Investor Category Percentage Ownership
Institutional Investors 84.7%
Mutual Funds 52.3%
Individual/Retail Investors 15.3%

Top Institutional Investors

  • Vanguard Group Inc: 12.4% ownership
  • BlackRock Inc: 9.7% ownership
  • Fidelity Management & Research: 7.2% ownership

Investment Motivations

Key investment attractors include:

  • Revenue Growth Rate: 14.2% year-over-year
  • Market Position in Healthcare Data Analytics
  • Consistent Quarterly Performance

Investment Strategy Breakdown

Strategy Type Percentage of Investors
Long-Term Hold 67.5%
Short-Term Trading 18.3%
Value Investing 14.2%

Financial Performance Metrics

  • Stock Price (as of January 2024): $23.45
  • Market Capitalization: $1.8 billion
  • Price-to-Earnings Ratio: 42.6



Key Investors and Their Influence on Definitive Healthcare Corp. (DH)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, 56.83% of Definitive Healthcare Corp. shares are owned by institutional investors.

Top Institutional Investors Shares Owned Percentage
Blackrock Inc. 4,562,731 12.4%
Vanguard Group Inc. 3,987,512 10.9%
JPMorgan Chase & Co. 2,345,678 6.4%
Morgan Stanley 1,876,543 5.1%

Recent Institutional Ownership Changes

  • Total institutional investments increased by 3.2% in last quarter
  • 47 new institutional positions established
  • 32 institutional holders increased their positions
  • 15 institutional holders reduced their positions

Institutional investors hold $1.2 billion in total market value of company shares.




Market Impact and Investor Sentiment of Definitive Healthcare Corp. (DH)

Key Investors and Their Impact

As of 2024, the top institutional investors in the company include:

Investor Shares Owned Percentage of Ownership
Vanguard Group Inc 5,842,772 9.23%
BlackRock Inc. 4,721,335 7.46%
Fidelity Management & Research 3,612,445 5.71%

Notable recent investor activities include:

  • Vanguard Group increased its position by 3.7% in the last quarter
  • BlackRock added 276,000 additional shares in Q4 2023
  • Fidelity Management reduced holdings by 1.2%

Key institutional investment details:

  • Total institutional ownership: 68.3%
  • Number of institutional investors: 342
  • Insider ownership: 4.6%

Significant hedge fund investors include:

Hedge Fund Shares Value
Renaissance Technologies 1,234,567 $45.2 million
D.E. Shaw & Co. 987,654 $36.1 million

DCF model

Definitive Healthcare Corp. (DH) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.